dc.contributor.author | Rosberg, Victoria | |
dc.contributor.author | Vishram-Nielsen, Julie KK | |
dc.contributor.author | Kristensen, Anna M. Dyrvig | |
dc.contributor.author | Pareek, Manan | |
dc.contributor.author | Sehested, Thomas S.G. | |
dc.contributor.author | Nilsson, Peter M | |
dc.contributor.author | Linneberg, Allan | |
dc.contributor.author | Palmieri, Luigi | |
dc.contributor.author | Giampaoli, Simona | |
dc.contributor.author | Donfrancesco, Chiara | |
dc.contributor.author | Kee, Frank | |
dc.contributor.author | Mancia, Giuseppe | |
dc.contributor.author | Cesana, Giancarlo | |
dc.contributor.author | Veronesi, Giovanni | |
dc.contributor.author | Grassi, Guido | |
dc.contributor.author | Kuulasmaa, Kari | |
dc.contributor.author | Salomaa, Veikko | |
dc.contributor.author | Palosaari, Tarja | |
dc.contributor.author | Sans, Susana | |
dc.contributor.author | Ferrieres, Jean | |
dc.contributor.author | Dallongeville, Jean | |
dc.contributor.author | Söderberg, Stefan | |
dc.contributor.author | Moitry, Marie | |
dc.contributor.author | Drygas, Wojciech | |
dc.contributor.author | Tamosiunas, Abdonas | |
dc.contributor.author | Peters, Annette | |
dc.contributor.author | Brenner, Hermann | |
dc.contributor.author | Schöttker, Ben | |
dc.contributor.author | Grimsgaard, Sameline | |
dc.contributor.author | Biering-Sørensen, Tor | |
dc.contributor.author | Olsen, Michael H | |
dc.date.accessioned | 2022-09-05T11:45:39Z | |
dc.date.available | 2022-09-05T11:45:39Z | |
dc.date.issued | 2022-01-27 | |
dc.description.abstract | To assess whether anthropometric measures (body mass index [BMI], waist-hip ratio [WHR], and estimated fat
mass [EFM]) are independently associated with major adverse cardiovascular events (MACE), and to assess their
added prognostic value compared with serum total-cholesterol. The study population comprised 109,509 individuals (53% men) from the MORGAM-Project, aged 19–97 years, without established cardiovascular disease,
and not on antihypertensive treatment. While BMI was reported in all, WHR and EFM were reported in ~52,000
participants. Prognostic importance of anthropometric measurements and total-cholesterol was evaluated using
adjusted Cox proportional-hazards regression, logistic regression, area under the receiver-operatingcharacteristic curve (AUCROC), and net reclassification improvement (NRI). The primary endpoint was MACE,
a composite of stroke, myocardial infarction, or death from coronary heart disease. Age interacted significantly
with anthropometric measures and total-cholesterol on MACE (P ≤ 0.003), and therefore age-stratified analyses
(<50 versus ≥ 50 years) were performed. BMI, WHR, EFM, and total-cholesterol were independently associated
with MACE (P ≤ 0.003) and resulted in significantly positive NRI when added to age, sex, smoking status, and
systolic blood pressure. Only total-cholesterol increased discrimination ability (AUCROC difference; P < 0.001). In
subjects < 50 years, the prediction model with total-cholesterol was superior to the model including BMI, but not
superior to models containing WHR or EFM, while in those ≥ 50 years, the model with total-cholesterol was
superior to all models containing anthropometric variables, whether assessed individually or combined. We
found a potential role for replacing total-cholesterol with anthropometric measures for MACE-prediction among
individuals < 50 years when laboratory measurements are unavailable, but not among those ≥ 50 years. | en_US |
dc.identifier.citation | Rosberg, Vishram-Nielsen, Kristensen, Pareek, Sehested, Nilsson, Linneberg, Palmieri, Giampaoli, Donfrancesco, Kee, Mancia, Cesana, Veronesi, Grassi, Kuulasmaa, Salomaa, Palosaari, Sans, Ferrieres, Dallongeville, Söderberg, Moitry, Drygas, Tamosiunas, Peters, Brenner, Schöttker, Grimsgaard, Biering-Sørensen, Olsen. Simple cardiovascular risk stratification by replacing total serum cholesterol with anthropometric measures: The MORGAM prospective cohort project. Preventive Medicine Reports. 2022;26 | en_US |
dc.identifier.cristinID | FRIDAID 2025232 | |
dc.identifier.doi | 10.1016/j.pmedr.2022.101700 | |
dc.identifier.issn | 2211-3355 | |
dc.identifier.uri | https://hdl.handle.net/10037/26640 | |
dc.language.iso | eng | en_US |
dc.publisher | Elsevier | en_US |
dc.relation.journal | Preventive Medicine Reports | |
dc.relation.projectID | info:eu-repo/grantAgreement/EC/FP5-LIFE QUALITY/QLG2-CT-2002-01254/EU/Genome-wide analyses of european twin and population cohorts to identify genes in common diseases/GENOMEUTWIN/ | en_US |
dc.relation.projectID | info:eu-repo/grantAgreement/EC/FP7-HEALTH/201413/EU/European Network for Genetic and Genomic Epidemiology/ENGAGE/ | en_US |
dc.relation.projectID | info:eu-repo/grantAgreement/EC/FP7-HEALTH/242244/EU/Consortium on Health and Ageing: Network of Cohorts in Europe and the United States/CHANGES/ | en_US |
dc.relation.projectID | info:eu-repo/grantAgreement/EC/FP7-HEALTH/278913/EU/Biomarker for Cardiovascular Risk Assessment in Europe/BIOMARCARE/ | en_US |
dc.relation.projectID | info:eu-repo/grantAgreement/EC/SOCIETAL CHALLENGES/825903/EU/An EU-Canada joint infrastructure for next-generation multi-Study Heart research/euCanSHare/ | en_US |
dc.relation.projectID | info:eu-repo/grantAgreement/EC/SOCIETAL CHALLENGES/847770/EU/DIGITAL, RISK-BASED SCREENING FOR ATRIAL FIBRILLATION IN THE EUROPEAN COMMUNITY/AFFECT-EU/ | en_US |
dc.rights.accessRights | openAccess | en_US |
dc.rights.holder | Copyright 2022 The Author(s) | en_US |
dc.title | Simple cardiovascular risk stratification by replacing total serum cholesterol with anthropometric measures: The MORGAM prospective cohort project | en_US |
dc.type.version | publishedVersion | en_US |
dc.type | Journal article | en_US |
dc.type | Tidsskriftartikkel | en_US |
dc.type | Peer reviewed | en_US |